Gluconic Acid

Gluconic Acid

SCHEMBL5065814

O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Na+].[Na+].[Na+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 1.00
PDE4A P27815 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.52
TDP1 Q9NUW8 1/20 0.50
USP2 O75604 1/20 0.50
SLCO1B1 Q9Y6L6 1/20 0.50
KDM4E B2RXH2 2/20 0.38
CA4 P22748 2/20 0.36
OR51E2 Q9H255 1/20 0.35
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL28185018 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL31213255 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL4007438 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL29431841 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL23640 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL30213455 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL29439913 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL30677856 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL2572507 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2
Gluconic Acid SCHEMBL23641 1.00 LMNA (1.00) LMNAPDE4AL3MBTL1TDP1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114959776-B Three-dimensional porous Ni-Mo-Cu catalyst and preparation method and application thereof 武汉理工大学 2024-05-07 CN claimed
US-20240035111-A1 BINDER COMPOSITION FOR THE PRODUCTION OF METAL ORE PELLETS, METHOD FOR THE PRODUCTION OF THE PELLETS AND METAL ORE PELLET AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) 2024-02-01 US claimed
WO-2022136070-A1 BINDER COMPOSITION FOR THE PRODUCTION OF METAL ORE PELLETS, METHOD FOR THE PRODUCTION OF THE PELLETS AND METAL ORE PELLET HOLCIM TECHNOLOGY LTD (CH) 2022-06-30 WO claimed
EP-4019481-A1 BINDER COMPOSITION FOR THE PRODUCTION OF METAL ORE PELLETS, METHOD FOR THE PRODUCTION OF THE PELLETS AND METAL ORE PELLET Holcim Technology Ltd (CH) 2022-06-29 EP claimed
US-9469902-B2 Electroless deposition of continuous platinum layer LAM RESEARCH CORPORATION (US) 2016-10-18 US claimed
US-20150232995-A1 ELECTROLESS DEPOSITION OF CONTINUOUS PLATINUM LAYER LAM RESEARCH CORPORATION (US) 2015-08-20 US claimed
CN-116390969-B Composition, silicone thermoplastic resin using same, and method for producing same 三菱瓦斯化学株式会社 2025-04-15 CN disclosed
WO-2024162437-A1 ABRASIVE SLURRY 三井金属鉱業株式会社 2024-08-08 WO disclosed
CN-114959776-B Three-dimensional porous Ni-Mo-Cu catalyst and preparation method and application thereof 武汉理工大学 2024-05-07 CN disclosed
CN-117903308-A Antagonistic anti-tumor necrosis factor receptor superfamily antibodies 综合医院公司 2024-04-19 CN disclosed
US-20240035111-A1 BINDER COMPOSITION FOR THE PRODUCTION OF METAL ORE PELLETS, METHOD FOR THE PRODUCTION OF THE PELLETS AND METAL ORE PELLET AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) 2024-02-01 US disclosed
CN-117321113-A Method for producing polycarbonate AGC株式会社 2023-12-29 CN disclosed
CN-109476745-B Antagonistic anti-tumor necrosis factor receptor superfamily antibodies 综合医院公司 2023-11-24 CN disclosed
WO-2022244856-A1 METHOD FOR PRODUCING POLYCARBONATE AGC株式会社 2022-11-24 WO disclosed
WO-2022136070-A1 BINDER COMPOSITION FOR THE PRODUCTION OF METAL ORE PELLETS, METHOD FOR THE PRODUCTION OF THE PELLETS AND METAL ORE PELLET HOLCIM TECHNOLOGY LTD (CH) 2022-06-30 WO disclosed
EP-4019481-A1 BINDER COMPOSITION FOR THE PRODUCTION OF METAL ORE PELLETS, METHOD FOR THE PRODUCTION OF THE PELLETS AND METAL ORE PELLET Holcim Technology Ltd (CH) 2022-06-29 EP disclosed
WO-2022025091-A1 LYOPHILIZED FORMULATION CONTAINING CEPHALOSPORIN HAVING CATECHOL GROUP, AND METHOD FOR PRODUCING SAME 塩野義製薬株式会社 2022-02-03 WO disclosed
US-9469902-B2 Electroless deposition of continuous platinum layer LAM RESEARCH CORPORATION (US) 2016-10-18 US disclosed
US-20150232995-A1 ELECTROLESS DEPOSITION OF CONTINUOUS PLATINUM LAYER LAM RESEARCH CORPORATION (US) 2015-08-20 US disclosed
EP-1935515-A2 A facility decontamination system Validated Hygiene Solutions Limited (GB) 2008-06-25 EP disclosed